{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:57:39Z","timestamp":1776380259351,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10354-021-00876-0","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T10:38:59Z","timestamp":1629715139000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination\u2014a\u00a0narrative review","Kutane und allergische Nebenwirkungen bei COVID-19-Vakzinierung\u00a0\u2013 ein narrativer Review"],"prefix":"10.1007","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5933-2913","authenticated-orcid":false,"given":"Uwe","family":"Wollina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Chiriac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hristina","family":"Kocic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Brzezinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"issue":"6","key":"876_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.arcmed.2020.04.016","volume":"51","author":"GI Perez Perez","year":"2020","unstructured":"Perez Perez\u00a0GI, Talebi Bezmin Abadi\u00a0A. Ongoing challenges faced in the global control of COVID-19 pandemic. Arch Med Res. 2020;51(6):574\u20136.","journal-title":"Arch Med Res"},{"key":"876_CR2","doi-asserted-by":"publisher","first-page":"664179","DOI":"10.3389\/fmed.2021.664179","volume":"8","author":"S Blumental","year":"2021","unstructured":"Blumental\u00a0S, Debr\u00e9\u00a0P. Challenges and issues of anti-SARS-CoV\u20112 vaccines. Front Med (Lausanne). 2021;8:664179.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"876_CR3","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/all.13561","volume":"73","author":"J Ring","year":"2018","unstructured":"Ring\u00a0J, Jutel\u00a0M, Papadopoulos\u00a0N, et\u00a0al. Provocative proposal for a\u00a0revised nomenclature for allergy and other hypersensitivity diseases. Allergy. 2018;73(10):1939\u201340.","journal-title":"Allergy"},{"issue":"15","key":"876_CR4","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/jama.2021.3976","volume":"325","author":"KG Blumenthal","year":"2021","unstructured":"Blumenthal\u00a0KG, Robinson\u00a0LB, Camargo\u00a0CA Jr, et al. Acute allergic reactions to mRNA COVID-19 vaccines. JAMA. 2021;325(15):1562\u20135.","journal-title":"JAMA"},{"issue":"27","key":"876_CR5","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack\u00a0FP, Thomas\u00a0SJ, Kitchin\u00a0N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N\u00a0Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"5","key":"876_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden\u00a0LR, El Sahly\u00a0HM, Essink\u00a0B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV\u20112 vaccine. N\u00a0Engl J Med. 2021;384(5):403\u201316.","journal-title":"N Engl J Med"},{"key":"876_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2021.04.001","author":"G Bogdanov","year":"2021","unstructured":"Bogdanov\u00a0G, Bogdanov\u00a0D, Kazandjieva\u00a0J, Tsankov\u00a0N. Cutaneous adverse effects of the available COVID-19 vaccines. Clin Dermatol. 2021; https:\/\/doi.org\/10.1016\/j.clindermatol.2021.04.001.","journal-title":"Clin Dermatol"},{"key":"876_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.03.055","author":"CL Ramos","year":"2021","unstructured":"Ramos\u00a0CL, Kelso\u00a0JM. \u201cCOVID arm\u201d: very delayed large injection site reactions to mRNA COVID-19 vaccines. J\u00a0Allergy Clin Immunol Pract. 2021; https:\/\/doi.org\/10.1016\/j.jaip.2021.03.055.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"876_CR9","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/IJGM.S310497","volume":"14","author":"NA El-Shitany","year":"2021","unstructured":"El-Shitany\u00a0NA, Harakeh\u00a0S, Badr-Eldin\u00a0SM, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021;14:1389\u2013401.","journal-title":"Int J Gen Med"},{"key":"876_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.1214","author":"MS Johnston","year":"2021","unstructured":"Johnston\u00a0MS, Galan\u00a0A, Watsky\u00a0KL, Little\u00a0AJ. Delayed localized hypersensitivity reactions to the Moderna COVID-19 vaccine: a\u00a0case series. JAMA Dermatol. 2021; https:\/\/doi.org\/10.1001\/jamadermatol.2021.1214.","journal-title":"JAMA Dermatol"},{"key":"876_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.092","author":"DE McMahon","year":"2021","unstructured":"McMahon\u00a0DE, Amerson\u00a0E, Rosenbach\u00a0M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414\u00a0cases. J\u00a0Am Acad Dermatol. 2021; https:\/\/doi.org\/10.1016\/j.jaad.2021.03.092.","journal-title":"J Am Acad Dermatol"},{"issue":"10249","key":"876_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","volume":"396","author":"FC Zhu","year":"2020","unstructured":"Zhu\u00a0FC, Guan\u00a0XH, Li\u00a0YH, et al. Immunogenicity and safety of a\u00a0recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18\u00a0years or older: a\u00a0randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020;396(10249):479\u201388.","journal-title":"Lancet"},{"key":"876_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00127-4","author":"S Yang","year":"2021","unstructured":"Yang\u00a0S, Li\u00a0Y, Dai\u00a0L, et al. Safety and immunogenicity of a\u00a0recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis. 2021; https:\/\/doi.org\/10.1016\/S1473-3099(21)00127-4.","journal-title":"Lancet Infect Dis"},{"issue":"10255","key":"876_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0140-6736(20)31866-3","volume":"396","author":"DY Logunov","year":"2020","unstructured":"Logunov\u00a0DY, Dolzhikova\u00a0IV, Zubkova\u00a0OV, et al. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2\u00a0studies from Russia. Lancet. 2020;396(10255):887\u201397.","journal-title":"Lancet"},{"key":"876_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17390","author":"D Mintoff","year":"2021","unstructured":"Mintoff\u00a0D, Pisani\u00a0D, Betts\u00a0A, Scerri\u00a0L. SARS-CoV\u20112 mRNA vaccine-associated fixed drug eruption. J\u00a0Eur Acad Dermatol Venereol. 2021; https:\/\/doi.org\/10.1111\/jdv.17390.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"876_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15000","author":"A Tammaro","year":"2021","unstructured":"Tammaro\u00a0A, Adebanjo\u00a0GAR, Parisella\u00a0FR, et al. Local reactions to the second dose of the BNT162 COVID-19 vaccine. Dermatol Ther. 2021; https:\/\/doi.org\/10.1111\/dth.15000.","journal-title":"Dermatol Ther"},{"key":"876_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-021-03803-x","author":"T Cantarelli Rodrigues","year":"2021","unstructured":"Cantarelli Rodrigues\u00a0T, Hidalgo\u00a0PF, Skaf\u00a0AY, Serfaty\u00a0A. Subacromial-subdeltoid bursitis following COVID-19 vaccination: a\u00a0case of shoulder injury related to vaccine administration (SIRVA). Skelet Radiol. 2021; https:\/\/doi.org\/10.1007\/s00256-021-03803-x.","journal-title":"Skelet Radiol"},{"issue":"2","key":"876_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13223-018-0283-4","volume":"14","author":"D Fischer","year":"2018","unstructured":"Fischer\u00a0D, Vander Leek\u00a0TK, Ellis\u00a0AK, Kim\u00a0H. Anaphylaxis. Allergy Asthma Clin Immunol. 2018;14(2):54.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"876_CR19","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","volume":"137","author":"MM McNeil","year":"2016","unstructured":"McNeil\u00a0MM, Weintraub\u00a0ES, Duffy\u00a0J, et\u00a0al. Risk of anaphylaxis after vaccination in children and adults. J\u00a0Allergy Clin Immunol. 2016;137(3):868\u201378.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"876_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/jama.2021.1967","volume":"325","author":"TT Shimabukuro","year":"2021","unstructured":"Shimabukuro\u00a0TT, Cole\u00a0M, Su\u00a0JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US\u2014december 14, 2020\u2013january 18, 2021. JAMA. 2021;325(11):1101\u20132.","journal-title":"JAMA"},{"key":"876_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17327","author":"M Kraft","year":"2021","unstructured":"Kraft\u00a0M, Renaudin\u00a0JM, Ensina\u00a0LF, et\u00a0al. Anaphylaxis to vaccination and polyethylene glycol (PEG): a perspective from the European anaphylaxis registry. J\u00a0Eur Acad Dermatol Venereol. 2021; https:\/\/doi.org\/10.1111\/jdv.17327.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"876_CR22","doi-asserted-by":"publisher","first-page":"108748","DOI":"10.1016\/j.clim.2021.108748","volume":"227","author":"V Erdeljic Turk","year":"2021","unstructured":"Erdeljic Turk\u00a0V. Anaphylaxis associated with the mRNA COVID-19 vaccines: approach to allergy investigation. Clin Immunol. 2021;227:108748. https:\/\/doi.org\/10.1016\/j.clim.2021.108748.","journal-title":"Clin Immunol"},{"key":"876_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.04.002","author":"KA Risma","year":"2021","unstructured":"Risma\u00a0KA, Edwards\u00a0KM, Hummell\u00a0DS, et al. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines. J\u00a0Allergy Clin Immunol. 2021; https:\/\/doi.org\/10.1016\/j.jaci.2021.04.002.","journal-title":"J Allergy Clin Immunol"},{"key":"876_CR24","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.214","author":"A Radice","year":"2021","unstructured":"Radice\u00a0A, Fassio\u00a0F, Meucci\u00a0E, et al. Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19 vaccine: not just PEG. Eur Ann Allergy Clin Immunol. 2021; https:\/\/doi.org\/10.23822\/EurAnnACI.1764-1489.214.","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"876_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.04.032","author":"A Troelnikov","year":"2021","unstructured":"Troelnikov\u00a0A, Perkins\u00a0G, Yuson\u00a0C, et\u00a0al. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in PEG allergic patients. J\u00a0Allergy Clin Immunol. 2021; https:\/\/doi.org\/10.1016\/j.jaci.2021.04.032.","journal-title":"J Allergy Clin Immunol"},{"issue":"19","key":"876_CR26","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/j.vaccine.2021.03.073","volume":"39","author":"S Hatziantoniou","year":"2021","unstructured":"Hatziantoniou\u00a0S, Maltezou\u00a0HC, Tsakris\u00a0A, et al. Anaphylactic reactions to mRNA COVID-19 vaccines: a call for further study. Vaccine. 2021;39(19):2605\u20137.","journal-title":"Vaccine"},{"issue":"1","key":"876_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.18176\/jiaci.0667","volume":"31","author":"ML Caballero","year":"2021","unstructured":"Caballero\u00a0ML, Quirce\u00a0S. Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of currently authorized COVID-19 vaccines. J\u00a0Investig Allergol Clin Immunol. 2021;31(1):92\u20133.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"5","key":"876_CR28","doi-asserted-by":"publisher","first-page":"100541","DOI":"10.1016\/j.waojou.2021.100541","volume":"14","author":"G Paoletti","year":"2021","unstructured":"Paoletti\u00a0G, Racca\u00a0F, Piona\u00a0A, et al. Successful SARS-coV\u20112 vaccine allergy risk-management: the experience of a\u00a0large Italian university hospital. World Allergy Organ\u00a0J. 2021;14(5):100541.","journal-title":"World Allergy Organ J"},{"issue":"4","key":"876_CR29","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.jaip.2020.12.047","volume":"9","author":"A Banerji","year":"2021","unstructured":"Banerji\u00a0A, Wickner\u00a0PG, Saff\u00a0R, et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J\u00a0Allergy Clin Immunol Pract. 2021;9(4):1423\u201337.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"876_CR30","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.jaip.2021.02.016","volume":"9","author":"BD Stone","year":"2021","unstructured":"Stone\u00a0BD. PEG skin testing for COVID-19 vaccine allergy. J\u00a0Allergy Clin Immunol Pract. 2021;9(4):1765.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"876_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usab138","author":"HJ Park","year":"2021","unstructured":"Park\u00a0HJ, Montgomery\u00a0JR, Boggs\u00a0NA. Anaphylaxis after the Covid-19 vaccine in a\u00a0patient with cholinergic urticaria. Mil Med. 2021; https:\/\/doi.org\/10.1093\/milmed\/usab138.","journal-title":"Mil Med"},{"issue":"6","key":"876_CR32","first-page":"e362","volume":"35","author":"J Ring","year":"2021","unstructured":"Ring\u00a0J, Worm\u00a0M, Wollenberg\u00a0A, et al. Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases\u2014practical recommendations. A position statement of ETFAD with external experts. J\u00a0Eur Acad Dermatol Venereol. 2021;35(6):e362\u2013e5.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"876_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s40629-021-00165-7","author":"L Klimek","year":"2021","unstructured":"Klimek\u00a0L, Bergmann\u00a0KC, Brehler\u00a0R, et al. Practical handling of allergic reactions to COVID-19 vaccines: a position paper from German and Austrian allergy societies AeDA, DGAKI, GPA and \u00d6GAI. Allergo J Int. 2021; https:\/\/doi.org\/10.1007\/s40629-021-00165-7.","journal-title":"Allergo J Int"},{"issue":"4","key":"876_CR34","doi-asserted-by":"publisher","first-page":"374","DOI":"10.36849\/JDD.6041","volume":"20","author":"RH Gotkin","year":"2021","unstructured":"Gotkin\u00a0RH, Gout\u00a0U, Sattler\u00a0S, et al. Global recommendations on COVID-19 vaccines and soft tissue filler reactions: a survey-based investigation in cooperation with the international society for Dermatologic and aesthetic surgery (ISDS). J\u00a0Drugs Dermatol. 2021;20(4):374\u20138.","journal-title":"J Drugs Dermatol"},{"key":"876_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17343","author":"E Farinazzo","year":"2021","unstructured":"Farinazzo\u00a0E, Ponis\u00a0G, Zelin\u00a0E, et al. Cutaneous adverse reactions after m\u2011RNA COVID-19 vaccine: early reports from North-East Italy. J\u00a0Eur Acad Dermatol Venereol. 2021; https:\/\/doi.org\/10.1111\/jdv.17343.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"876_CR36","doi-asserted-by":"publisher","first-page":"13030\/qt4xs486z","DOI":"10.5070\/D3271052044","volume":"27","author":"PM Jedlowski","year":"2021","unstructured":"Jedlowski\u00a0PM, Jedlowski\u00a0MF. Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine. Dermatol Online\u00a0J. 2021;27(1):13030\/qt4xs486zg.","journal-title":"Dermatol Online J"},{"issue":"5","key":"876_CR37","first-page":"e13549","volume":"33","author":"U Wollina","year":"2020","unstructured":"Wollina\u00a0U, Karada\u011f\u00a0AS, Rowland-Payne\u00a0C, et al. Cutaneous signs in COVID-19\u00a0patients: a review. Dermatol Ther. 2020;33(5):e13549.","journal-title":"Dermatol Ther"},{"key":"876_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27036","author":"E Eid","year":"2021","unstructured":"Eid\u00a0E, Abdullah\u00a0L, Kurban\u00a0M, Abbas\u00a0O. Herpes zoster emergence following mRNA COVID-19 vaccine. J\u00a0Med Virol. 2021; https:\/\/doi.org\/10.1002\/jmv.27036.","journal-title":"J Med Virol"},{"key":"876_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jdcr.2021.04.014","volume":"12","author":"P Rodr\u00edguez-Jim\u00e9nez","year":"2021","unstructured":"Rodr\u00edguez-Jim\u00e9nez\u00a0P, Chicharro\u00a0P, Cabrera\u00a0LM, et al. Varicella-zoster virus reactivation after SARS-CoV\u20112 BNT162b2 mRNA vaccination: report of 5\u00a0cases. JAAD Case Rep. 2021;12:58\u20139.","journal-title":"JAAD Case Rep"},{"key":"876_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab345","author":"V Furer","year":"2021","unstructured":"Furer\u00a0V, Zisman\u00a0D, Kibari\u00a0A, et al. Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a\u00a0case series. Rheumatology (Oxford). 2021; https:\/\/doi.org\/10.1093\/rheumatology\/keab345.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"876_CR41","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/vaccines9060572","volume":"9","author":"M Psichogiou","year":"2021","unstructured":"Psichogiou\u00a0M, Samarkos\u00a0M, Mikos\u00a0N, Hatzakis\u00a0A. Reactivation of varicella zoster virus after vaccination for SARS-CoV\u20112. Vaccines (Basel). 2021;9(6):572. https:\/\/doi.org\/10.3390\/vaccines9060572.","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"876_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7241\/ourd.2020S2.7","volume":"11","author":"P Brzezinski","year":"2020","unstructured":"Brzezinski\u00a0P, Wollina\u00a0U. HSV infections during the COVID-19 pandemic. Our Dermatol Online. 2020;11(2):19\u201320.","journal-title":"Our Dermatol Online"},{"issue":"4","key":"876_CR43","first-page":"e14453","volume":"13","author":"EZ Lopatynsky-Reyes","year":"2021","unstructured":"Lopatynsky-Reyes\u00a0EZ, Acosta-Lazo\u00a0H, Ulloa-Gutierrez\u00a0R, et al. BCG Scar local skin inflammation as a\u00a0novel reaction following mRNA COVID-19 vaccines in two international healthcare workers. Cureus. 2021;13(4):e14453.","journal-title":"Cureus"},{"issue":"2","key":"876_CR44","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41418-020-00720-9","volume":"28","author":"G Forni","year":"2021","unstructured":"Forni\u00a0G, Mantovani\u00a0A, COVID-19 Commission of Accademia Nazionale dei Lincei, Rome. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ. 2021;28(2):626\u201339.","journal-title":"Cell Death Differ"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-021-00876-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10354-021-00876-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-021-00876-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T10:15:31Z","timestamp":1646648131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10354-021-00876-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":44,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["876"],"URL":"https:\/\/doi.org\/10.1007\/s10354-021-00876-0","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]},"assertion":[{"value":"3 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"U.\u00a0Wollina, A.\u00a0Chiriac, H.\u00a0Kocic, A.\u00a0Koch, and P.\u00a0Brzezinski declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}